Impax Laboratories Reports First Quarter 2011 Financial Results
Impax Laboratories, Inc.reported first quarter ended March 31, 2011 financial results. Larry Hsu, Ph.D., president...
IMS Institute Reports U.S. Spending on Medicines Grew 2.3 Percent in 2010, to $307.4...
The IMS Institute for Healthcare Informatics today reported a 2.3 percent increase in spending on...
Novo Nordisk increased operating profit by 27% in 2010
Organic sales growth of 19% driven by Victoza®, NovoRapid® and Levemir® Sales increased by 19%...
Pfizer Reports Fourth-Quarter and Full-Year 2010 Results
Pfizer Inc.reported financial results for fourth-quarter and full-year 2010. Since the acquisition of Wyeth was...
Innovation drives Novartis to double-digit growth for 2010
Novartis achieved strong financial results in 2010 -Net sales up 14% (+14% in constant currencies,...
Genzyme Financial Recovery Continues in Fourth Quarter
Genzyme Corp. reported that preliminary fourth-quarter revenue grew 23 percent to $1.15 billion from $938...
IMS Health Forecasts Global Pharmaceutical Market Growth of 5-7 Percent in 2011, Reaching $880...
The value of the global pharmaceutical market is expected to grow 5-7 percent in 2011,...
BioMimetic Therapeutics Reports 2010 Third Quarter Earnings Results
BioMimetic Therapeutics, Inc. reported its financial results as of and for the three and nine...
GlaxoSmithKline announced third quarter results-Net Sales growth of 14% compared to the previous quarter
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the third quarter ended 30th September...
Bayer lifts sales-Grow by 16.1 percent to EUR 8,581 million
The Bayer Group significantly raised sales and underlying earnings in the third quarter of 2010....
